ETCHX
Price
$42.33
Change
+$0.32 (+0.76%)
Updated
Nov 18 closing price
Net Assets
1.57B
FSPHX
Price
$30.12
Change
-$0.01 (-0.03%)
Updated
Nov 18 closing price
Net Assets
6.22B
Interact to see
Advertisement

ETCHX vs FSPHX

Header iconETCHX vs FSPHX Comparison
Open Charts ETCHX vs FSPHXBanner chart's image
Eventide Healthcare & Life Sciences C
Price$42.33
Change+$0.32 (+0.76%)
VolumeN/A
Net Assets1.57B
Fidelity Select Health Care
Price$30.12
Change-$0.01 (-0.03%)
VolumeN/A
Net Assets6.22B
ETCHX vs FSPHX Comparison Chart in %
View a ticker or compare two or three
VS
ETCHX vs. FSPHX commentary
Nov 20, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ETCHX is a Hold and FSPHX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
FSPHX has more cash in the bank: 6.22B vs. ETCHX (1.57B). FSPHX pays higher dividends than ETCHX: FSPHX (0.02) vs ETCHX (0.00). ETCHX was incepted earlier than FSPHX: ETCHX (13 years) vs FSPHX (44 years). ETCHX (2.32) is less costly to investors than FSPHX (0.63). ETCHX (41.00) and FSPHX (40.00) have comparable annual turnover. FSPHX has a lower initial minimum investment than ETCHX: FSPHX (0) vs ETCHX (1000). ETCHX annual gain was more profitable for investors over the last year : 42.21 vs. FSPHX (0.35). FSPHX return over 5 years is better than : -8.45 vs. ETCHX (-12.90).
ETCHXFSPHXETCHX / FSPHX
Total Expense Ratio2.320.63368%
Annual Report Gross Expense Ratio2.320.63368%
Fund Existence13 years44 years-
Gain YTD43.67310.569413%
Front LoadN/AN/A-
Min. Initial Investment10000-
Min. Initial Investment IRAN/AN/A-
Net Assets1.57B6.22B25%
Annual Yield % from dividends0.000.02-
Returns for 1 year42.210.3512,063%
Returns for 3 years51.2810.51488%
Returns for 5 years-12.90-8.45153%
Returns for 10 years80.7939.39205%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
SPMHX8.480.01
+0.12%
Invesco SteelPath MLP Alpha R5
PEMGX42.33N/A
N/A
Principal MidCap A
BRUFX564.44N/A
N/A
Bruce
REMVX11.11N/A
N/A
RBC Emerging Markets Value Equity I
CVTCX55.08-0.41
-0.74%
Calamos Growth & Income C